Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes

References

1. 1.↵
   2. Louis DN,
   3. Perry A,
   4. Reifenberger G, et al

   . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20

   CrossRefPubMed
2. 2.↵
   2. Kepes JJ,
   3. Chen WY,
   4. Connors MH, et al

   . “Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome: a report of seven cases. Cancer 1988;62:391–406 doi:10.1002/1097-0142(19880715)62:2<391::AID-CNCR2820620226>3.0.CO;2-7 pmid:3383139

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Yang Y,
   3. Li D,
   4. Cao XY, et al

   . Clinical features, treatment, and prognostic factors of chordoid meningioma: radiological and pathological features in 60 cases of chordoid meningioma. World Neurosurg 2016;93:198–207 doi:10.1016/j.wneu.2016.03.097 pmid:27060511

   CrossRefPubMed
4. 4.↵
   2. Couce ME,
   3. Aker FV,
   4. Scheithauer BW

   . Chordoid meningioma: a clinicopathologic study of 42 cases. Am J Surg Pathol 2000;24:899–905 doi:10.1097/00000478-200007000-00001 pmid:10895812

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Epari S,
   3. Sharma MC,
   4. Sarkar C, et al

   . Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J Neurooncol 2006;78:263–69 doi:10.1007/s11060-005-9092-y pmid:16628477

   CrossRefPubMed
6. 6.↵
   2. Carpeggiani P,
   3. Crisi G,
   4. Trevisan C

   . MRI of intracranial meningiomas: correlations with histology and physical consistency. Neuroradiology 1993;35:532–36 doi:10.1007/BF00588715 pmid:8232883

   CrossRefPubMed
7. 7.↵
   2. Zimmerman RD,
   3. Fleming CA,
   4. Saint-louis LA, et al

   . Magnetic resonance imaging of meningiomas. AJNR Am J Neuroradiol 1985;6:149–57 pmid:3920874

   Abstract/FREE Full Text
8. 8.↵
   2. Coroller TP,
   3. Bi WL,
   4. Huynh E, et al

   . Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One 2017;12:e0187908 doi:10.1371/journal.pone.0187908 pmid:29145421

   CrossRefPubMed
9. 9.↵
   2. Nakasu S,
   3. Nakasu Y,
   4. Nakajima M, et al

   . Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999;90:455–62 pmid:10067913

   PubMed
10. 10.↵
    2. Watts J,
    3. Box G,
    4. Galvin A, et al

    . Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging 2014;5:113–22 doi:10.1007/s13244-013-0302-4 pmid:24399610

    CrossRefPubMed
11. 11.↵
    2. Filippi CG,
    3. Edgar MA,
    4. Uluğ AM, et al

    . Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001;22:65–72 pmid:11158890

    Abstract/FREE Full Text
12. 12.↵
    2. Nagar VA,
    3. Ye JR,
    4. Ng WH, et al

    . Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol 2008;29:1147–52 doi:10.3174/ajnr.A0996 pmid:18356472

    Abstract/FREE Full Text
13. 13.↵
    2. Pond JB,
    3. Morgan TG,
    4. Hatanpaa KJ, et al

    . Chordoid meningioma: differentiating a rare World Health Organization grade II tumor from other meningioma histologic subtypes using MRI. AJNR Am J Neuroradiol 2015;36:1253–58 doi:10.3174/ajnr.A4309 pmid:25882286

    Abstract/FREE Full Text
14. 14.↵
    2. Nagata S,
    3. Nishimura H,
    4. Uchida M, et al

    . Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med 2008;26:287–95 doi:10.1007/s11604-008-0229-8 pmid:18661213

    CrossRefPubMed
15. 15.↵
    2. Yeom KW,
    3. Lober RM,
    4. Mobley BC, et al

    . Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma. AJNR Am J Neuroradiol 2013;34:1056–61, S1 doi:10.3174/ajnr.A3333 pmid:23124635

    Abstract/FREE Full Text
16. 16.↵
    2. Yang S,
    3. Law M,
    4. Zagzag D, et al

    . Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003;24:1554–59 pmid:13679270

    Abstract/FREE Full Text
17. 17.↵
    2. Zhang H,
    3. Rödiger LA,
    4. Shen T, et al

    . Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology 2008;50:525–30 doi:10.1007/s00234-008-0373-y pmid:18379768

    CrossRefPubMed
18. 18.↵
    2. Gihr GA,
    3. Horvath-Rizea D,
    4. Garnov N, et al

    . Diffusion profiling via a histogram approach distinguishes low-grade from high-grade meningiomas, can reflect the respective proliferative potential and progesterone receptor status. Mol Imaging Biol 2018;20:632–40 doi:10.1007/s11307-018-1166-2 pmid:29392542

    CrossRefPubMed
19. 19.↵
    2. Schob S,
    3. Surov A,
    4. Wienke A, et al

    . Correlation between aquaporin 4 expression and different DWI parameters in grade I meningioma. Mol Imaging Biol 2017;19:138–42 doi:10.1007/s11307-016-0978-1 pmid:27357591

    CrossRefPubMed
20. 20.↵
    2. Schob S,
    3. Frydrychowicz C,
    4. Gawlitza M, et al

    . Signal intensities in preoperative MRI do not reflect proliferative activity in meningioma. Transl Oncol 2016;9:274–79 doi:10.1016/j.tranon.2016.05.003 pmid:27567949

    CrossRefPubMed
21. 21.↵
    2. Gihr GA,
    3. Horvath-Rizea D,
    4. Kohlhof-Meinecke P, et al

    . Histogram profiling of postcontrast T1-weighted MRI gives valuable insights into tumor biology and enables prediction of growth kinetics and prognosis in meningiomas. Transl Oncol 2018;11:957–61 doi:10.1016/j.tranon.2018.05.009 pmid:29909365

    CrossRefPubMed